Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.

30. Mai 2006

Twelves, C.J., 2006.

Clin Colorectal Cancer 6, 278–287.

Abstract